Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]

(Mineralocorticoid antagonists [aldosterone antagonists] )

Rare males and females disease from the section "". Causes not a significant loss of workdays. Not mortally.

11 992 people were diagnosed with Mineralocorticoid antagonists [aldosterone antagonists]

0 died with a diagnosis of Mineralocorticoid antagonists [aldosterone antagonists]

0 % disease mortality Mineralocorticoid antagonists [aldosterone antagonists]

Mineralocorticoid antagonists [aldosterone antagonists] is diagnosed to women at 159.47% more often than men

3 336

Men are diagnosed with Mineralocorticoid antagonists [aldosterone antagonists]. There were no deaths.

0 %

mortality in men with disease Mineralocorticoid antagonists [aldosterone antagonists]

95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

8 656

Women are diagnosed with Mineralocorticoid antagonists [aldosterone antagonists] There were no deaths.

0 %

mortality in women with disease Mineralocorticoid antagonists [aldosterone antagonists]

Risk group for the disease Mineralocorticoid antagonists [aldosterone antagonists] men aged 25-29 and women aged65-69

The disease is most common in men aged 25-29

In men, the disease is least likely to occur at the age of 0-1, 5-24, 30-44, 50-54, 60-69, 85+

In women, the disease is least likely to occur at the age of 0-59, 85-94

The disease is most common in women aged 65-69

Features of the disease Mineralocorticoid antagonists [aldosterone antagonists]

Absence or low individual and social danger

* - Medical statistics for the whole group of diseases Y54 Препараты, влияющие преимущественно на водный баланс, минеральный обмен и обмен мочевой кислоты

Diagnostics

Standard for diagnosing the disease Mineralocorticoid antagonists [aldosterone antagonists] not found

Diagnosis Mineralocorticoid antagonists [aldosterone antagonists] on the 1 place in the frequency of diseases in the rubric of other Drugs, medicaments and biological substances causing adverse effects in therapeutic use diseases

Most common:

Mineralocorticoid antagonists [aldosterone antagonists] disease on the 1 most dangerous disease in the category of other Drugs, medicaments and biological substances causing adverse effects in therapeutic use diseases

Most dangerous:


* - Medical statistics for the whole group of diseases Y54 Препараты, влияющие преимущественно на водный баланс, минеральный обмен и обмен мочевой кислоты

Treatment

The standard for the treatment of the disease Mineralocorticoid antagonists [aldosterone antagonists] is not is established

8 days required for doctors in inpatient treatment

Average time for outpatient admission is not established

0 medical procedures are provided for the treatment of Mineralocorticoid antagonists [aldosterone antagonists]


* - Medical statistics for the whole group of diseases Y54 Препараты, влияющие преимущественно на водный баланс, минеральный обмен и обмен мочевой кислоты

Diseases with similar symptoms

Single spontaneous delivery

Single spontaneous delivery ,

One of the most popular female diseases from the section "Delivery". Causes not a significant loss of workdays. Not mortally.

Low risk, only women get sick, age 13-57

Liveborn infants according to place of birth

Liveborn infants according to place of birth ,

One of the most popular males and females diseases from the section "Persons encountering health services in circumstances related to reproduction". Causes not a significant loss of workdays. Not mortally.

Low risk, sick men and women, age 0-0

Fall on same level from slipping, tripping and stumbling

Fall on same level from slipping, tripping and stumbling ,

One of the most popular males and females diseases from the section "Falls". Causes not a significant loss of workdays. May be the cause of death.

Medium risk, sick men and women, age 1-100

Heart failure

Heart failure ,

One of the most popular males and females diseases from the section "Other forms of heart disease". Causes not a significant loss of workdays. May be the cause of death.

High risk, sick men and women, any age

Possible Symptoms